Mario A. Shields

2.7k total citations
25 papers, 1.1k citations indexed

About

Mario A. Shields is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Mario A. Shields has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Mario A. Shields's work include Pancreatic and Hepatic Oncology Research (14 papers), Cancer Cells and Metastasis (9 papers) and TGF-β signaling in diseases (4 papers). Mario A. Shields is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Cancer Cells and Metastasis (9 papers) and TGF-β signaling in diseases (4 papers). Mario A. Shields collaborates with scholars based in United States, United Kingdom and Australia. Mario A. Shields's co-authors include Hidayatullah G. Munshi, Surabhi Dangi‐Garimella, Seth B. Krantz, Amanda J. Redig, David J. Bentrem, Paul J. Grippo, David J. Bentrem, David J. Bentrem, Morgan R. Barron and Michael J. Heiferman and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Mario A. Shields

23 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mario A. Shields United States	16	609	504	235	143	121	25	1.1k
Vanessa Baeriswyl Switzerland	12	452 0.7×	728 1.4×	190 0.8×	150 1.0×	70 0.6×	14	1.1k
Htoo Zarni Oo Canada	21	453 0.7×	743 1.5×	347 1.5×	121 0.8×	151 1.2×	54	1.2k
Nikolaos A. Dallas United States	13	711 1.2×	889 1.8×	451 1.9×	117 0.8×	91 0.8×	16	1.4k
Christophe Schneider France	19	307 0.5×	617 1.2×	242 1.0×	307 2.1×	75 0.6×	41	1.1k
Ralf Jesnowski Germany	18	664 1.1×	554 1.1×	198 0.8×	140 1.0×	312 2.6×	35	1.1k
Clifford J. Whatcott United States	13	773 1.3×	518 1.0×	237 1.0×	279 2.0×	97 0.8×	42	1.3k
Shaija Samuel United States	14	739 1.2×	972 1.9×	433 1.8×	126 0.9×	89 0.7×	16	1.5k
Christine Mehner United States	14	339 0.6×	423 0.8×	284 1.2×	96 0.7×	42 0.3×	23	849
Kirsten L. Bryant United States	9	416 0.7×	853 1.7×	537 2.3×	129 0.9×	77 0.6×	20	1.2k
Ewa Zając United States	14	457 0.8×	528 1.0×	309 1.3×	445 3.1×	71 0.6×	20	1.2k

Countries citing papers authored by Mario A. Shields

Since Specialization

Citations

This map shows the geographic impact of Mario A. Shields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario A. Shields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario A. Shields more than expected).

Fields of papers citing papers by Mario A. Shields

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario A. Shields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario A. Shields. The network helps show where Mario A. Shields may publish in the future.

Co-authorship network of co-authors of Mario A. Shields

This figure shows the co-authorship network connecting the top 25 collaborators of Mario A. Shields. A scholar is included among the top collaborators of Mario A. Shields based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario A. Shields. Mario A. Shields is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spaulding, Christina, Alejandra M. Marinelarena, Mario A. Shields, et al.. (2024). Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRAS G12D Inhibitor MRTX1133 in Pancreatic Cancer. Cancer Research. 84(21). 3629–3639. 3 indexed citations

Pham, Thao D., et al.. (2024). Trametinib Potentiates Anti-PD-1 Efficacy in Tumors Established from Chemotherapy-Primed Pancreatic Cancer Cells. Molecular Cancer Therapeutics. 23(12). 1854–1865. 1 indexed citations

Shields, Mario A., Christina Spaulding, Tomonori Hirose, et al.. (2024). BET Inhibition Rescues Acinar-Ductal-Metaplasia and Ciliogenesis and Ameliorates Chronic Pancreatitis-Driven Changes in Mice With Loss of the Polarity Protein Par3. Cellular and Molecular Gastroenterology and Hepatology. 18(5). 101389–101389.

Pham, Thao D., Christina Spaulding, Mario A. Shields, et al.. (2022). Inhibition of MNKs promotes macrophage immunosuppressive phenotype to limit CD8+ T cell antitumor immunity. JCI Insight. 7(9). 15 indexed citations

Shields, Mario A., et al.. (2022). Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin. Cell Reports. 38(9). 110441–110441. 6 indexed citations

Barth, Nicole D., Ramon Subirós‐Funosas, Lorena Mendive‐Tapia, et al.. (2020). A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis. Nature Communications. 11(1). 4027–4027. 59 indexed citations

Pham, Thao D., Mario A. Shields, Christina Spaulding, et al.. (2019). Quercetin Enhances the Anti-Tumor Effects of BET Inhibitors by Suppressing hnRNPA1. International Journal of Molecular Sciences. 20(17). 4293–4293. 48 indexed citations

Ebine, Kazumi, Krishan Kumar, Thao D. Pham, et al.. (2018). Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells. Scientific Reports. 8(1). 13225–13225. 30 indexed citations

Shields, Mario A., Seth B. Krantz, David J. Bentrem, Surabhi Dangi‐Garimella, & Hidayatullah G. Munshi. (2012). Interplay between β1-Integrin and Rho Signaling Regulates Differential Scattering and Motility of Pancreatic Cancer Cells by Snail and Slug Proteins. Journal of Biological Chemistry. 287(9). 6218–6229. 57 indexed citations

10.

Krantz, Seth B., Mario A. Shields, Surabhi Dangi‐Garimella, et al.. (2011). MT1-MMP Cooperates with KrasG12D to Promote Pancreatic Fibrosis through Increased TGF-β Signaling. Molecular Cancer Research. 9(10). 1294–1304. 52 indexed citations

11.

Shields, Mario A., Surabhi Dangi‐Garimella, Seth B. Krantz, David J. Bentrem, & Hidayatullah G. Munshi. (2011). Pancreatic Cancer Cells Respond to Type I Collagen by Inducing Snail Expression to Promote Membrane Type 1 Matrix Metalloproteinase-dependent Collagen Invasion. Journal of Biological Chemistry. 286(12). 10495–10504. 100 indexed citations

12.

Krantz, Seth B., Mario A. Shields, Surabhi Dangi‐Garimella, Hidayatullah G. Munshi, & David J. Bentrem. (2011). Contribution of Epithelial-to-Mesenchymal Transition and Cancer Stem Cells to Pancreatic Cancer Progression. Journal of Surgical Research. 173(1). 105–112. 72 indexed citations

13.

Ward, Sarah, et al.. (2011). Ethanol differentially regulates snail family of transcription factors and invasion of premalignant and malignant pancreatic ductal cells. Journal of Cellular Biochemistry. 112(10). 2966–2973. 6 indexed citations

14.

Shields, Mario A., Surabhi Dangi‐Garimella, Amanda J. Redig, & Hidayatullah G. Munshi. (2011). Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression. Biochemical Journal. 441(2). 541–552. 161 indexed citations

15.

Dangi‐Garimella, Surabhi, Seth B. Krantz, Morgan R. Barron, et al.. (2010). Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP–Mediated Expression of HMGA2. Cancer Research. 71(3). 1019–1028. 142 indexed citations

16.

Dangi‐Garimella, Surabhi, et al.. (2010). Rho-ROCK-Myosin Signaling Meditates Membrane Type 1 Matrix Metalloproteinase-induced Cellular Aggregation of Keratinocytes. Journal of Biological Chemistry. 285(36). 28363–28372. 14 indexed citations

17.

Katsoulidis, Efstratios, Evangelos Mavrommatis, Jennifer Woodard, et al.. (2010). Role of Interferon α (IFNα)-inducible Schlafen-5 in Regulation of Anchorage-independent Growth and Invasion of Malignant Melanoma Cells. Journal of Biological Chemistry. 285(51). 40333–40341. 75 indexed citations

18.

Krantz, Seth B., Surabhi Dangi‐Garimella, Mario A. Shields, et al.. (2010). Role of MT1-MMP and Kras in invasive pancreatic tumors with pronounced fibrosis.. Journal of Clinical Oncology. 28(15_suppl). 4158–4158.

19.

Joseph, Mathew J., Surabhi Dangi‐Garimella, Mario A. Shields, et al.. (2009). Slug is a downstream mediator of transforming growth factor‐β1‐induced matrix metalloproteinase‐9 expression and invasion of oral cancer cells. Journal of Cellular Biochemistry. 108(3). 726–736. 73 indexed citations

20.

Shields, Mario A., et al.. (2008). Inhibition of CYP1A1 by Quassinoids Found inPicrasma excelsa. Planta Medica. 75(2). 137–141. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact